Researchers investigated the issue of race and equality of access to clinical trials. The table below shows the population distribution and the numbers of participants in clinical trials involving lung cancer.

What are the null and alternative hypotheses for this goodness-of-fit test?

If we use the significance level 0.01 do we reject or fail to reject the null hypothesis?

If we use the 0.01 significance level, state your conclusion for the hypothesis test. Is there a race/ethnic group that appears to be very underrepresented? Explain.

Race/ethnicity	White Non-Hispanic	Hispanic	Black	Asian/Pacific Islander	American Indian/ Alaskan Native
Distribution of Population	75.6%	9.1%	10.8%	3.8%	0.7%
Number in Lung Cancer Clinical Trials	3855	60	316	54	12